Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products-Reference-Cited by-同舟云学术

Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products

Published:2014-05-22 Issue:6 Volume:77 Page:939-946
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Johnston John D.¹,Feldschreiber Peter²

Affiliation:

1. c/o 1102-35 Indescon Square; London UK

2. c/o 4 New Square; London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12250/fullpdf

Reference17 articles.

1. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use 2012 http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf

2. Workshop on personalised medicine 2010 http://ec.europa.eu/research/health/pdf/summary-report-omics-for-personalised-medicine-workshop_en.pdf

3. The 1000 Genomes Project: paving the way for personalized genomic medicine;Gibson;Pers Med,2013

4. Enabling personalized medicine in Europe: a look at the European Commission's funding activities in the field of personalized medicine research;Draghia-Akli;Pers Med,2012

5. Challenges posed to the European pharmaceutical regulatory system by highly-personalized medicines;Johnston;Br J Clin Pharmacol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage Therapy Regulation: From Night to Dawn;Viruses;2019-04-17

2. Guidelines for Bacteriophage Product Certification;Methods in Molecular Biology;2017-11-09

3. From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients;Clinical Pharmacology & Therapeutics;2015-02-04

4. The licence for a custom-made medicinal product is an adaptive licence;British Journal of Clinical Pharmacology;2014-05-22